Literature DB >> 8040259

The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.

R W Burlingame1, M L Boey, G Starkebaum, R L Rubin.   

Abstract

To gain insight into the mechanisms of autoantibody induction, sera from 40 patients with systemic lupus erythematosus (SLE) were tested by ELISAs for antibody binding to denatured individual histones, native histone-histone complexes, histone-DNA subnucleosome complexes, three forms of chromatin, and DNA. Whole chromatin was the most reactive substrate, with 88% of the patients positive. By chi-square analysis, only the presence of anti-(H2A-H2B), anti-[(H2A-H2B)-DNA], and antichromatin were correlated with kidney disease measured by proteinuria > 0.5 g/d. SLE patients could be divided into two groups based on their antibody-binding pattern to the above substrates. Antibodies from about half of the patients reacted with chromatin and the (H2A-H2B)-DNA subnucleosome complex but displayed very low or no reactivity with native DNA or the (H3-H4)2-DNA subnucleosome complex. An additional third of the patients had antibody reactivity to chromatin, as well as to both subnucleosome structures and DNA. Strikingly, all sera that bound to any of the components of chromatin also bound to whole chromatin, and adsorption with chromatin removed 85-100% of reactivity to (H2A-H2B)-DNA, (H3-H4)2-DNA, and native DNA. Individual sera often bound to several different epitopes on chromatin, with some epitopes requiring quaternary protein-DNA interactions. These results are consistent with chromatin being a potent immunogenic stimulus in SLE. Taken together with previous studies, we suggest that antibody activity to the (H2A-H2B)-DNA component signals the initial breakdown of immune tolerance whereas responses to (H3-H4)2-DNA and native DNA reflect subsequent global loss of tolerance to chromatin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040259      PMCID: PMC296296          DOI: 10.1172/JCI117305

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  A new procedure for the isolation and fractionation of histones.

Authors:  D R. van der Westhuyzen; C von Holt
Journal:  FEBS Lett       Date:  1971-05-20       Impact factor: 4.124

2.  Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F1 mouse.

Authors:  T N Marion; D M Tillman; N T Jou
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

3.  Circular dichroism and thermal denaturation studies of subnucleosomes and their relationships to nucleosome structure.

Authors:  A J Mencke; R L Rill
Journal:  Biochemistry       Date:  1982-08-31       Impact factor: 3.162

4.  Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus.

Authors:  D A Isenberg; Y Shoenfeld; R S Schwartz
Journal:  Arthritis Rheum       Date:  1984-02

5.  Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus.

Authors:  M C Totoritis; E M Tan; E M McNally; R L Rubin
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

6.  Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology.

Authors:  M Okamura; Y Kanayama; K Amastu; N Negoro; S Kohda; T Takeda; T Inoue
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

7.  Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions.

Authors:  J P Portanova; R E Arndt; E M Tan; B L Kotzin
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

8.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.

Authors:  M Shlomchik; M Mascelli; H Shan; M Z Radic; D Pisetsky; A Marshak-Rothstein; M Weigert
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

9.  Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis.

Authors:  T M Schmiedeke; F W Stöckl; R Weber; Y Sugisaki; S R Batsford; A Vogt
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

10.  Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.

Authors:  C Mohan; S Adams; V Stanik; S K Datta
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  67 in total

1.  Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.

Authors:  R Cervera; O Viñas; M Ramos-Casals; J Font; M García-Carrasco; A Sisó; F Ramírez; Y Machuca; J Vives; M Ingelmo; R W Burlingame
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 2.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

3.  Acrylamine-induced autoimmune phenomena.

Authors:  Bruce Rothschild
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

4.  Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.

Authors:  M Koshy; D Berger; M K Crow
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  The evolution of human anti-double-stranded DNA autoantibodies.

Authors:  Ute Wellmann; Miriam Letz; Martin Herrmann; Sieglinde Angermüller; Joachim R Kalden; Thomas H Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

6.  Autoimmunity stimulated by adoptively transferred dendritic cells is initiated by both alphabeta and gammadelta T cells but does not require MyD88 signaling.

Authors:  David A Martin; Kang Zhang; Justin Kenkel; Grant Hughes; Edward Clark; Anne Davidson; Keith B Elkon
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

7.  Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus.

Authors:  B P Tsao; R M Cantor; K C Kalunian; C J Chen; H Badsha; R Singh; D J Wallace; R C Kitridou; S L Chen; N Shen; Y W Song; D A Isenberg; C L Yu; B H Hahn; J I Rotter
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 8.  T cells of lupus and molecular targets for immunotherapy.

Authors:  S K Datta; A Kaliyaperumal; A Desai-Mehta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 9.  Autoantibodies to the RoRNP particles.

Authors:  M Reichlin
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

10.  Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus.

Authors:  Adel A Shabana; Atef E El-Ghawet; Shereen A Machaly; Ekbal M Abu Hashim; Basma A El-Kady; Reham Shaat
Journal:  Clin Rheumatol       Date:  2009-03-14       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.